Session Three: To explore ways in which we can increase investment in innovation. Part 2 presents a case study of innovation across the globe and the need to continue global collaboration Marc Wortman, Executive Director, Alzheimer’s Disease International (ADI)

1. 1
*Includes grants, contracts, and other funding mechanisms used across the National Institutes of Health.
**Includes heart disease ($1.38), coronary heart disease ($457M), cardiovascular disease ($2.14B), and stroke
($337M).
Sources: MetLife Foundation; National Institutes of Health
While AD Is the Second-Most Feared Health Condition
in the US, it Remains Poorly Funded
% People Who Fear it Most Annual Public Research Funding ($billions)*
AD AD

2. National Dementia Plans
Countries with National Dementia Plans
http://www.alz.co.uk/alzheimer-plans
• Australia
• Belgium
• Denmark
• Finland
• France
• Japan
• Luxembourg
• South Korea
• Switzerland
• Netherlands
• Norway
• Taiwan
• UK (plans for England,
Scotland, Northern
Ireland and Wales)
• USA

3. Member countries 2014-15

4. Global Alzheimer’s and
Dementia Action Alliance
• Response to call upon Civil Society in Declaration of
the Summit
• Launched at World Health Assembly 19 May 2014
• Purpose is to tackle global stigma by building
commitment and actions at international level and
sharing best practices
• Open for international non-governmental
organisations (NGOs)
• Each member will commit to an action plan
• First meeting alongside UN Review of NCDs 10 July

5. Ageing, NCDs, Dementia
and Mental Health
Ageing
Dementia
Mental health
NCDs

6. Ageing, NCDs, Dementia
and Mental Health
Ageing
Dementia
Mental health
NCDs